Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Thymoma 1Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Multiple Myeloma 1Multidisciplinary Collaborative 1Lymphoma 1Lung Neoplasms 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Advanced Malignant Solid Neoplasm 1

Interventions

Cyclophosphamide 7pembrolizumab 6Radiotherapy 6Cisplatin 6Sunitinib 5Carboplatin 5Paclitaxel 4Thymectomy 3130-nm albumin-bound paclitaxel 3selinexor 2lenvatinib 2fludarabine 2Taxes 2Robotic Surgical Procedures 2Ramucirumab 2Prednisone 2Pemetrexed 2Octreotide 2Nivolumab 2N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2Methylprednisolone 2Imatinib Mesylate 2Etoposide 2Erlotinib Hydrochloride 2Doxorubicin 2Chemoradiotherapy 2Celecoxib 2zimberelimab 1vorolanib 1saracatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thymoma × Patient Comfort × Clear all
NCT04662645 2023-10-26

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers

Ohio State University Comprehensive Cancer Center

Phase NA Completed
68 enrolled
Thoracic

Lung Neoplasms, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡